Pediatric Nephrology for Primary Care

Total Page:16

File Type:pdf, Size:1020Kb

Pediatric Nephrology for Primary Care Pediatric Nephrology for Primary Care Amin J. Barakat and Russell W. Chesney Editors American Academy of Pediatrics 141 Northwest Point Blvd Elk Grove Village, IL 60007-1098 AAP Department of Marketing and Publications Maureen DeRosa, MPA, Director, Department of Marketing and Publications Mark Grimes, Director, Division of Product Development Diane Lundquist, Senior Product Development Editor Sandi King, MS, Director, Division of Publishing and Production Services Kate Larson, Manager, Editorial Services Theresa Wiener, Manager, Editorial Production Peg Mulcahy, Graphic Designer Jill Ferguson, Director, Division of Marketing Linda Smessaert, Manager, Clinical and Professional Publications Marketing Robert Herling, Director, Division of Sales Library of Congress Control Number: 2008941470 ISBN: 978-1-58110-297-0 MA0441 The recommendations in this publication do not indicate an exclusive course of treatment or serve as a standard of medical care. Variations, taking into account individual circumstances, may be appropriate. Copyright © 2009 American Academy of Pediatrics. All rights reserved. No part of this publication may be reproduced, stored in a retrieval system, or transmitted, in any form or by any means, electronic, mechanical, photo copying, recording, or otherwise, without prior written permission from the publisher. Printed in the United States of America. 9-200/1108 Last digit is the print number: 9 8 7 6 5 4 3 2 1 iii Contributors Alfred Z. Abuhamad, MD Professor and Chairman, Department of Obstetrics and Gynecology, Eastern Virginia School of Medicine, Norfolk, VA Uri S. Alon, MD Professor of Pediatrics, Director of Bone and Mineral Disorders Clinic, Section of Pediatric Nephrology, Children’s Mercy Hospital and Clinics, University of Missouri Kansas City School of Medicine, Kansas City, MO Sharon P. Andreoli, MD Byron P. and Frances D. Hollett Professor of Pediatrics, Department of Pediatrics, James Whitcomb Riley Hospital for Children, Indiana University Medical Center, Indianapolis, IN Billy S. Arant, Jr, MD, FAAP Professor, Department of Pediatrics, University of Tennessee College of Medicine, Chattanooga, TN Bettina H. Ault, MD Associate Professor, Department of Pediatrics, University of Tennessee Health Science Center, Memphis, TN Amin J. Barakat, MD, FAAP Clinical Professor, Department of Pediatrics, Georgetown University School of Medicine, Washington, DC Eliza M. F. Berkley, MD Assistant Professor, Division of Maternal Fetal Medicine, Department of Obstetrics and Gynecology, Eastern Virginia Medical School, Norfolk, VA Eileen D. Brewer, MD, FAAP Professor and Head, Pediatric Renal Section, Baylor College of Medicine, and Chief, Renal Service at Texas Children’s Hospital, Houston, TX Douglas A. Canning, MD Chief, Division of Urology, University of Pennsylvania School of Medicine, Children’s Hospital of Philadelphia, Philadelphia, PA iv Pediatric Nephrology for Primary Care Andy Yu-How Chang, MD Assistant Professor, Division of Pediatric Urology, Children’s Hospital Los Angeles, Keck School of Medicine, University of Southern California, Los Angeles, CA Russell W. Chesney, MD, FAAP Le Bonheur Professor and Chair, Department of Pediatrics, The University of Tennessee Health Science Center, Memphis, TN Noel M. Delos Santos, MD Assistant Professor of Pediatrics and Pediatric Nephrology, University of Tennessee Health Science Center, Memphis, TN Agnes B. Fogo, MD Professor of Pathology, Medicine and Pediatrics, and Director of the Renal/ Electron Microscopy Laboratory, Vanderbilt University Medical Center, Nashville, TN John Foreman, MD, FAAP Professor and Chief, Division of Pediatric Nephrology, Duke University Medical Center, Durham, NC Aaron Friedman, MD, FAAP Professor and Chairman, Department of Pediatrics, Brown Medical School, Hasbro Children’s Hospital, Providence, RI Uttam Garg, PhD Professor of Pathology, Director of Clinical Chemistry and Toxicology, Department of Pathology and Laboratory Medicine, Children’s Mercy Hospital and Clinics, University of Missouri Kansas City School of Medicine, Kansas City, MO M. Colleen Hastings, MD Assistant Professor, Departments of Pediatrics and Internal Medicine, University of Tennessee Health Sciences Center, Children’s Foundation Research Center at Le Bonheur Children’s Medical Center, Memphis, TN Iekuni Ichikawa, MD Professor of Pediatrics and Medicine, Vanderbilt University School of Medicine, Nashville, TN, and Professor of Bioethics, Tokai University School of Medicine, Isehara, Japan Contributors v Deborah P. Jones, MD Professor of Pediatrics, University of Tennessee Health Science Center, Children’s Foundation Research Center at Le Bonheur Children’s Medical Center, Memphis, TN Fumio Niimura, MD Associate Professor of Pediatrics, Tokai University School of Medicine, Isehara, Japan H. Norman Noe, MD, FAAP, FACS Professor of Urology and Chief, Division of Pediatric Urology, University of Tennessee, Memphis College of Medicine, Le Bonheur Children’s Medical Center, Memphis, TN Victoria F. Norwood, MD Professor of Pediatrics and Chief, Pediatric Nephrology, University of Virginia Children’s Hospital, Charlottesville, VA H. Gil Rushton, MD, FAAP Professor of Urology and Pediatrics, The George Washington Univer- sity School of Medicine, and Chief, Division of Pediatric Urology, Children’s National Medical Center, Washington, DC Nina Salhab, MS, RD/LD Pediatric Renal Dietician, Department of Pediatrics, University of Texas Southwestern Medical School at Dallas, Children’s Medical Center of Dallas, Dallas, TX S. Sedberry-Ross, MD Chief Resident, Department of Urology, George Washington University School of Medicine, Washington, DC Mouin G. Seikaly, MD, FAAP Professor of Pediatrics, University of Texas Southwestern Medical School at Dallas, and Chief of Solid Organ Transplant Program, Children’s Medical Center of Dallas, Dallas, TX Tarak Srivastava, MD Assistant Professor of Pediatrics, Section of Pediatric Nephrology, Children’s Mercy Hospital and Clinics, University of Missouri Kansas City School of Medicine, Kansas City, MO vi Pediatric Nephrology for Primary Care Mark A. Williams, MD, FAAP, FACS Assistant Professor, Department of Urology, University of Tennessee College of Medicine, Le Bonheur Children’s Medical Center, Memphis, TN Robert J. Wyatt, MD Chief, Division of Pediatric Nephrology, University of Tennessee Health Science Center, Children’s Foundation Research Center at Le Bonheur Children’s Medical Center, Memphis, TN Aida Yared, MD, FAAP Assistant Professor of Pediatrics, Vanderbilt University School of Medicine, Nashville, TN To our children, our grandchildren, and the children of the world, who inspire us to work harder for a better life for all. ix Contents Foreword .............................................................................................................................. xi Preface ................................................................................................................................ xiii Chapter 1. Presentation of Patients With Renal Disease and Guidelines for Patient Referral: Amin J. Barakat .......................................................... 1 Chapter 2. History and Physical Examination of the Child With Renal Disease: Aida Yared and Amin J. Barakat................................................ 13 Chapter 3. Examination of the Urine: Agnes B. Fogo and Amin J. Barakat ........... 33 Chapter 4. The Role of the Clinical Laboratory in the Diagnosis of Renal Disease: Tarak Srivastava, Uttam Garg, and Uri S. Alon ....................... 57 Chapter 5. Imaging of the Kidney and Urinary Tract: S. Sedberry-Ross and H. Gil Rushton............................................................................................. 77 Chapter 6. Urinary Tract Infection: Billy S. Arant, Jr .............................................. 119 Chapter 7. Hematuria: Noel M. Delos Santos and Bettina H. Ault ........................ 143 Chapter 8. Proteinuria: Victoria F. Norwood ........................................................... 159 Chapter 9. Glomerular Disease: M. Colleen Hastings and Robert J. Wyatt .......... 173 Chapter 10. Renal Tubular Disease: Russell W. Chesney .......................................... 193 Chapter 11. Water and Electrolyte Disorders: Aaron Friedman .............................. 213 Chapter 12. Acid-Base Disturbances: Fumio Niimura and Iekuni Ichikawa .......... 229 Chapter 13. Acute Kidney Injury: Sharon P. Andreoli .............................................. 247 Chapter 14. Chronic Kidney Disease: Mouin G. Seikaly and Nina Salhab ............ 267 Chapter 15. Hypertension: Deborah P. Jones .............................................................. 287 Chapter 16. Genetic Diseases of the Kidney: John Foreman .................................... 313 Chapter 17. Prenatal Diagnosis of Renal and Urinary Tract Abnormalities: Eliza M. F. Berkley and Alfred Z. Abuhamad ........................................ 333 Chapter 18. Pediatric Urology and Congenital Anomalies of the Kidney and Urinary Tract: Andy Y. Chang and Douglas A. Canning ..................... 351 Chapter 19. Renal Calculi: Mark A. Williams and H. Norman Noe ........................ 381 Chapter 20. The Kidney in Systemic Disease: Eileen D. Brewer .............................. 397 Chapter 21. Prevention of Kidney Disease: Amin J. Barakat ................................... 419 Appendices ....................................................................................................................... 433 Appendix
Recommended publications
  • Characteristics of Presentation and Metabolic Risk Factors in Relation to Extent of Involvement in Infants with Nephrolithiasis
    DOI: 10.14744/ejmi.2019.87741 EJMI 2020;4(1):78–85 Research Article Characteristics of Presentation and Metabolic Risk Factors in Relation to Extent of Involvement in Infants with Nephrolithiasis Kenan Yilmaz,1 Mustafa Erman Dorterler2 1Department of Pediatric Nephrolog, Sanliurfa Training and Research Hospital, Sanliurfa, Turkey 2Department of Pediatric Surgery, Harran University Faculty of Medicine, Sanliurfa, Turkey Abstract Objectives: To evaluate the characteristics of presentation and metabolic risk factors in relation to the extent of in- volvement in infants with nephrolithiasis. Methods: A total of 111 infants (age range 0.3–11.8 months, 58.6% were girls) diagnosed with nephrolithiasis in the first year of life were included in this retrospective study. Data on age at diagnosis, gender, family history of nephrolithiasis, parental consanguinity, symptoms on admission, urinary abnormalities, surgery, size of renal calculi, and metabolic risk factors (hypercalciuria, hyperuricosuria, hyperoxaluria, hypocitraturia, cystinuria, hypercalcemia) were recorded for each patient and compared with the number of kidneys affected (bilateral vs. unilateral), the number of kidney stones (multiple vs. single), and the kidney stone size (microlithiasis vs. larger stones). Results: Overall, 58.6% of the infants were girls. Irritability was the most common symptom on admission (34.2%). Microlithiasis (62.2%), bilateral kidney involvement (61.3%), multiple kidney stones (73.9%), and metabolic risk fac- tors (45.0%, hypercalciuria in 31.5%) were commonly noted. Bilateral nephrolithiasis was associated with significantly higher rates of hypercalciuria than unilateral nephrolithiasis (39.7% vs. 18.6%, respectively; p=0.022). The presence of multiple kidney stones was associated with a significantly higher rate of hyperuricosuria than the presence of a single kidney stone (20.7% vs.
    [Show full text]
  • Thomas Addis (1881—1949): Mixing Patients, Rats, and Politics
    View metadata, citation and similar papers at core.ac.uk brought to you by CORE provided by Elsevier - Publisher Connector Kidney International, Vol. 37 (1990), pp. 833—840 HISTORICAL ARCHIVE CARL W. GOi-FSCHALK, EDITOR Thomas Addis (1881—1949): Mixing patients, rats, and politics STEVEN J. PEITZMAN Department of Medicine, Division of Nephrology and Hypertension, The Medical College of Pennsylvania, Philadelphia, Pennsylvania, USA In the early decades of the twentieth century, with the threatat the Laboratory of the Royal College of Physicians of Edin- of epidemic infectious diseases already in decline, attentionburgh, one of Great Britain's pioneering medical research shifted to the chronic maladies: hypertension, atherosclerosis,enterprises, also supported by the Carnegie Trusts. obesity, cancer, diabetes—and nephritis, or Bright's disease. Ray Lyman Wilbur (1875—1949), dean of the young Stanford New chemical methods devised by Otto Folin (1867—1934) atMedical School in 1911, "thought it would be a good thing to Harvard and Donald D. Van Slyke (1883—1971) at the Rock-bring in a young scientist from Scotland if the right one could be efeller Institute Hospital empowered the investigation of renalfound who had been trained in German as well as British and metabolic disorders. Folin's colorimetric system provideduniversities, and who was likely to develop in some promising rapid measurement of creatinine, urea, and uric acid, while Vanfield of research" [3]. So Wilbur sent a cable of invitation to Slyke's gasometric analyses allowed quantification of urea andEdinburgh, and the young Scotsman accepted the unlikely total carbon dioxide. Also in the first decades of the twentiethposition: in 1911 Stanford was still a relatively isolated and century, the reform of medical schools provided new opportu-little-known medical school in San Francisco (the school moved nities for academic medical careers.
    [Show full text]
  • Recommendations for the Management of Bladder Bowel
    & The ics ra tr pe a u i t i d c e s P Santos et al., Pediat Therapeut 2014, 4:1 Pediatrics & Therapeutics DOI: 10.4172/2161-0665.1000191 ISSN: 2161-0665 Review Article Open Access Recommendations for the Management of Bladder Bowel Dysfunction in Children Joana dos Santos1*, Abby Varghese2, Katharine Williams2 and Martin A Koyle2 1Division of Pediatric Nephrology and Medical Urology, The Hospital for Sick Children, Toronto, Canada 2Division of Pediatric Urology, The Hospital for Sick Children. Toronto, Canada Abstract Bladder Bowel dysfunction (BBD) represents a broad term used to describe a multitude of conditions associated with incontinence or Urinary Tract Infections (UTI) that commonly is seen in primary Family and/or Pediatrics care. The BBD spectrum includes lower urinary tract conditions such as overactive bladder and urge incontinence, voiding postponement, underactive bladder, and voiding dysfunction, and, importantly, also includes bowel issues, as constipation and encopresis. BBD is often not recognised by family or child or even the referring professional, but it is the secondary symptoms of wetting or UTI, that prompts the child to be evaluated by a consultant. The goal of this review is to provide a practical guideline for diagnosis and management of BBD in children, common problem in daily pediatric practice. Most importantly, considering that most of these issues are functional, is that the majority of these children are best evaluated and treatment instituted by the primary provider, with referral to a specialist, only in exceptional cases. Keywords: Bladder bowel dysfunction; Lower urinary tract importantly, most of these children likely can be evaluated and treatment symptoms; Dysfunctional elimination syndrome; Urinary tract instituted without early referral to a specialist.
    [Show full text]
  • Lower Urinary Tract Symptoms (LUTS) in Middle-Aged and Elderly Men
    Ⅵ Prostatic Diseases Lower Urinary Tract Symptoms (LUTS) in Middle-Aged and Elderly Men JMAJ 47(12): 543–548, 2004 Tomonori YAMANISHI Associate Professor, Department of Urology, Dokkyo University School of Medicine Abstract: Lower urinary tract symptoms (LUTS) include storage symptoms (previously termed as irritative symptoms), voiding symptoms (previously termed as obstructive symptoms) and post-micturition symptoms. The International Continence Society (ICS) published a new standardization of terminology of lower urinary tract function in 2002. Storage symptoms include increased daytime frequency, nocturia, urgency and incontinence. Of incontinence, stress, urge and mixed incontinence are the major symptoms, and ICS has also defined enuresis, continuous incontinence and giggle incontinence as other types of incontinence. Urgency, with or without urge incontinence, usually with frequency and nocturia, can be described as overactive bladder (OAB) syndrome, urge syndrome, or urgency/frequency syndrome. These syndromes suggest urodynamically demon- strable detrusor overactivity, but may be due to other forms of urethro-vesical dysfunction. Overactive bladder is an empirical diagnosis used as the basis for initial management after assessing lower urinary tract symptoms, physical findings urinalysis, and other indicated evaluation. Voiding symptoms include slow stream, splitting or spraying, intermittency, hesitancy, straining and terminal dribble. Post micturition symptoms include a feeling of incomplete emptying and post micturition dribble. The “feeling of incomplete emptying” symptom was formerly categorized as either a storage symptom or a voiding symptom, but has been categorized among the post micturition symptoms in the new ICS terminology. “Post micturition dribble” is the term used when an individual describes the involuntary loss of urine immediately after he/she has finished passing urine, usually in men after leaving the toilet.
    [Show full text]
  • Acute Kidney Injury in Cancer Patients
    Acute kidney injury in cancer patients Bruno Nogueira César¹ Marcelino de Souza Durão Júnior¹ ² 1. Disciplina de Nefrologia, Universidade Federal de São Paulo, São Paulo, SP, Brasil 2. Unidade de Transplante Renal Hospital Israelita Albert Einstein, São Paulo, SP, Brasil http://dx.doi.org/10.1590/1806-9282.66.S1.25 SUMMARY The increasing prevalence of neoplasias is associated with new clinical challenges, one of which is acute kidney injury (AKI). In addition to possibly constituting a clinical emergency, kidney failure significantly interferes with the choice and continuation of antineoplastic therapy, with prognostic implications in cancer patients. Some types of neoplasia are more susceptible to AKI, such as multiple myeloma and renal carcinoma. In cancer patients, AKI can be divided into pre-renal, renal (intrinsic), and post-renal. Conventional platinum-based chemotherapy and new targeted therapy agents against cancer are examples of drugs that cause an intrinsic renal lesion in this group of patients. This topic is of great importance to the daily practice of nephrologists and even constitutes a subspecialty in the field, the onco-nephrology. KEYWORDS: Acute Kidney Injury. Neoplasia. Malignant tumor. Chemotherapy. INTRODUCTION With the epidemiological transition of recent de- (CT), compromises the continuation of treatment, cades, cancer has become the object of several clini- and limits the participation of patients in studies cal studies that resulted in more options for the diag- with new drugs. nosis and treatment of the disease. Thus, there was an increase in the survival of patients, and handling EPIDEMIOLOGY complications of the disease and treatment adverse effects also became more common1.
    [Show full text]
  • Simplified Quantitative Methods for Bacteriuria and Pyuria
    J Clin Pathol: first published as 10.1136/jcp.16.1.32 on 1 January 1963. Downloaded from J. clin. Path. (1963), 16, 32 Simplified quantitative methods for bacteriuria and pyuria JAMES McGEACHIE AND ARTHUR C. KENNEDY From the University Departments of Bacteriology and Medicine, Royal Infirmary, Glasgow SYNOPSIS Although pyelonephritis is a common disease, it escapes clinical detection in an un- desirably high proportion of patients. The present unsatisfactory diagnostic position would be much improved by widespread screening of patients by simple yet reasonably accurate methods. Bacterial counts by the pour-plate technique and estimates of the white cell excretion per hour or day, while undoubtedly of diagnostic value, are probably unsuitable for use on a wide scale. In an attempt to find more convenient procedures a simplified stroke-plate method of bacterial counting and a simplified quantitative white cell count method were devised and applied to over 1,000 mid-stream urine samples from 398 patients. Good correlation was obtained between the simpler stroke-plate method of bacterial counting and the more time-consuming pour-plate method. The quantitative white cell procedure was a much more sensitive index of pyuria than wet-film micro- scopy, and comparison with the bacterial count results showed that it gave a useful indication of urinary infection. It is suggested that a quantitative bacterial count should replace non-quantitativecopyright. culture methods when urinary infection is suspected and that the quantitative white cell count should be performed as a routine part of the initial clinical and laboratory assessment of all patients, followed by a bacterial count if pyuria is revealed.
    [Show full text]
  • Renal Agenesis, Renal Tubular Dysgenesis, and Polycystic Renal Diseases
    Developmental & Structural Anomalies of the Genitourinary Tract DR. Alao MA Bowen University Teach Hosp Ogbomoso Picture test Introduction • Congenital Anomalies of the Kidney & Urinary Tract (CAKUT) Objectives • To review the embryogenesis of UGS and dysmorphogenesis of CAKUT • To describe the common CAKUT in children • To emphasize the role of imaging in the diagnosis of CAKUT Introduction •CAKUT refers to gross structural anomalies of the kidneys and or urinary tract present at birth. •Malformation of the renal parenchyma resulting in failure of normal nephron development as seen in renal dysplasia, renal agenesis, renal tubular dysgenesis, and polycystic renal diseases. Introduction •Abnormalities of embryonic migration of the kidneys as seen in renal ectopy (eg, pelvic kidney) and fusion anomalies, such as horseshoe kidney. •Abnormalities of the developing urinary collecting system as seen in duplicate collecting systems, posterior urethral valves, and ureteropelvic junction obstruction. Introduction •Prevalence is about 3-6 per 1000 births •CAKUT is one of the commonest anomalies found in human. •It constitute approximately 20 to 30 percent of all anomalies identified in the prenatal period •The presence of CAKUT in a child raises the chances of finding congenital anomalies of other organ-systems Why the interest in CAKUT? •Worldwide, CAKUT plays a causative role in 30 to 50 percent of cases of end-stage renal disease (ESRD), •The presence of CAKUT, especially ones affecting the bladder and lower tract adversely affects outcome of kidney graft after transplantation Why the interest in CAKUT? •They significantly predispose the children to UTI and urinary calculi •They may be the underlying basis for urinary incontinence Genes & Environment Interact to cause CAKUT? • Tens of different genes with role in nephrogenesis have been identified.
    [Show full text]
  • High Urinary Calcium Excretion and Genetic Susceptibility to Hypertension and Kidney Stone Disease
    High Urinary Calcium Excretion and Genetic Susceptibility to Hypertension and Kidney Stone Disease Andrew Mente,* R. John D’A. Honey,† John M. McLaughlin,* Shelley B. Bull,* and Alexander G. Logan* *Prosserman Centre for Health Research, Samuel Lunenfeld Research Institute, Mount Sinai Hospital, and Department of Public Health Sciences, and †St. Michael’s Hospital, Division of Urology, Department of Surgery, University of Toronto, Toronto, Ontario, Canada Increased urinary calcium excretion commonly is found in patients with hypertension and kidney stone disease (KSD). This study investigated the aggregation of hypertension and KSD in families of patients with KSD and hypercalciuria and explored whether obesity, excessive weight gain, and diabetes, commonly related conditions, also aggregate in these families. Consec- utive patients with KSD, aged 18 to 50 yr, were recruited from a population-based Kidney Stone Center, and a 24-h urine and their spouse were interviewed by telephone (333 ؍ sample was collected. The first-degree relatives of eligible patients (n to collect demographic and health information. Familial aggregation was assessed using generalized estimating equations. Multivariate-adjusted odds ratios (OR) revealed significant associations between hypercalciuria in patients and hypertension (OR 2.9; 95% confidence interval 1.4 to 6.2) and KSD (OR 1.9; 95% confidence interval 1.03 to 3.5) in first-degree relatives, specifically in siblings. No significant associations were found in parents or spouses or in patients with hyperuricosuria. Similarly, no aggregation with other conditions was observed. In an independent study of siblings of hypercalciuric patients with KSD, the adjusted mean fasting urinary calcium/creatinine ratio was significantly higher in the hypertensive siblings compared with normotensive siblings (0.60 ؎ 0.32 versus 0.46 ؎ 0.28 mmol/mmol; P < 0.05), and both sibling groups had significantly higher values than the unselected study participants (P < 0.001).
    [Show full text]
  • 1 This Document Was Originally Published in May 2012, and Last
    MEDICAL STUDENT EDUCATION CURRICULUM This document was originally published in May 2012, and last amended in April 2020. This document will continue to be periodically updated to reflect the growing body of literature related to this topic. ADULT UTI Keywords: Urinary tract infection (UTI); cystitis; pyelonephritis; uropathogens; antibiotics. LEARNING OBJECTIVES: At the end of this unit, the student will be able to: 1. Outline the prevalence and socioeconomic impact of adult UTI 2. List the distinctions between urinary infection, contamination and colonization in diagnosing a UTI 3. List the important host and bacterial characteristics associated with a clinically important UTI 4. Name the most common gram negative and gram positive bacteria associated with adult UTI 5. Name the predominant organisms constituting normal perineal flora 6. List methods of urine collection and the advantages of each 7. Describe the different signs and symptoms associated with upper tract and lower tract adult UTIs 8. Describe and perform chemical and microscopic urinalysis, and its limits in the diagnosis of adult UTI 9. Name dominant pathogens or disease entities that need to be considered in the differential diagnosis of UTI 10. Describe the differences between complicated and uncomplicated adult UTI 11. List indications and use of imaging modalities in the diagnosis of adult UTI 12. Outline treatment principles of both complicated and uncomplicated adult UTIs including cystitis, pyelonephritis, epididymitis, and prostatitis Introduction Urinary tract infections are a troubling and increasingly dangerous condition treated by physicians from a number of specialties, including Urology. The landscape of diagnosis and management is changing as new resistance patterns emerge.
    [Show full text]
  • Young People with Urinary Incontinence
    GUIDE Transition Care and Urology Networks Young people with urinary incontinence Health professional guide Collaboration. Innovation. Better Healthcare. The Agency for Clinical Innovation (ACI) works with clinicians, consumers and managers to design and promote better healthcare for NSW. It does this by: • service redesign and evaluation – applying redesign methodology to assist healthcare providers and consumers to review and improve the quality, effectiveness and efficiency of services • specialist advice on healthcare innovation – advising on the development, evaluation and adoption of healthcare innovations from optimal use through to disinvestment • initiatives including guidelines and models of care – developing a range of evidence-based healthcare improvement initiatives to benefit the NSW health system • implementation support – working with ACI Networks, consumers and healthcare providers to assist delivery of healthcare innovations into practice across metropolitan and rural NSW • knowledge sharing – partnering with healthcare providers to support collaboration, learning capability and knowledge sharing on healthcare innovation and improvement • continuous capability building – working with healthcare providers to build capability in redesign, project management and change management through the Centre for Healthcare Redesign. ACI Clinical Networks, Taskforces and Institutes provide a unique forum for people to collaborate across clinical specialties and regional and service boundaries to develop successful healthcare innovations.
    [Show full text]
  • Article Twenty-Four Hour Urine Testing and Prescriptions For
    CJASN ePress. Published on November 11, 2019 as doi: 10.2215/CJN.03580319 Article Twenty-Four Hour Urine Testing and Prescriptions for Urinary Stone Disease–Related Medications in Veterans Shen Song,1 I-Chun Thomas,2 Calyani Ganesan,1 Ericka M. Sohlberg ,3 Glenn M. Chertow,1 Joseph C. Liao,2,3 Simon Conti,2,3 Christopher S. Elliott,3,4 Alan C. Pao,1,2,3 and John T. Leppert1,2,3 Abstract Background and objectives Current guidelines recommend 24-hour urine testing in the evaluation and treatment 1Division of of persons with high-risk urinary stone disease. However, how much clinicians use information from 24-hour Nephrology, urine testing to guide secondary prevention strategies is unknown. We sought to determine the degree to which Departments of clinicians initiate or continue stone disease–related medications in response to 24-hour urine testing. Medicine and 3Urology, Stanford Design, setting, participants, & measurements We examined a national cohort of 130,489 patients with incident University School of Medicine, Stanford, urinary stone disease in the Veterans Health Administration between 2007 and 2013 to determine whether California; 2Veterans prescription patterns for thiazide diuretics, alkali therapy, and allopurinol changed in response to 24-hour urine Affairs Palo Alto testing. Health Care System, Palo Alto, California; 4 fi and Division of Results Stone formers who completed 24-hour urine testing (n=17,303; 13%) were signi cantly more likely to be Urology, Santa Clara prescribed thiazide diuretics, alkali therapy, and allopurinol compared with those who did not complete a 24-hour Valley Medical Center, urine test (n=113,186; 87%).
    [Show full text]
  • Interpretation of Canine and Feline Urinalysis
    $50. 00 Interpretation of Canine and Feline Urinalysis Dennis J. Chew, DVM Stephen P. DiBartola, DVM Clinical Handbook Series Interpretation of Canine and Feline Urinalysis Dennis J. Chew, DVM Stephen P. DiBartola, DVM Clinical Handbook Series Preface Urine is that golden body fluid that has the potential to reveal the answers to many of the body’s mysteries. As Thomas McCrae (1870-1935) said, “More is missed by not looking than not knowing.” And so, the authors would like to dedicate this handbook to three pioneers of veterinary nephrology and urology who emphasized the importance of “looking,” that is, the importance of conducting routine urinalysis in the diagnosis and treatment of diseases of dogs and cats. To Dr. Carl A. Osborne , for his tireless campaign to convince veterinarians of the importance of routine urinalysis; to Dr. Richard C. Scott , for his emphasis on evaluation of fresh urine sediments; and to Dr. Gerald V. Ling for his advancement of the technique of cystocentesis. Published by The Gloyd Group, Inc. Wilmington, Delaware © 2004 by Nestlé Purina PetCare Company. All rights reserved. Printed in the United States of America. Nestlé Purina PetCare Company: Checkerboard Square, Saint Louis, Missouri, 63188 First printing, 1998. Laboratory slides reproduced by permission of Dennis J. Chew, DVM and Stephen P. DiBartola, DVM. This book is protected by copyright. ISBN 0-9678005-2-8 Table of Contents Introduction ............................................1 Part I Chapter 1 Sample Collection ...............................................5
    [Show full text]